Population
Differentiated cultured myoblasts and patients with myotonic dystrophy (DM)
Design
Preclinical
Authors
Loading...
May explain DMPK loss via nuclear retention in myotonic dystrophy models; leaves open human relevance and therapeutic targeting.
The study identifies nuclear retention of mutant transcripts as a novel mechanism for loss of gene function in myotonic dystrophy.
Davis et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: